Complex Linear Wound Closure | Optimal Wound Closure
X

SUTUREGARD® MEDICAL INC. Blog

 
Archive by author: SUTUREGARD® Medical, Inc.Return
JAAD Case Reports recently published, “Use of a novel adhesive suture retention wound closure device to prevent follow-up visits during the COVID-19 pandemic”; a case study demonstrating patient self-removal of sutures after wound closure repair.
Read More
Bill Lear, MD, Mohs surgeon now but 5-year emergency physician previously, talks with Dr. Mark Plaster of Emergency Physician Monthly about how being an ER doc nurtured his inventive skills which eventually led to his development of the HEMIGARD ARS device. The HEMIGARD ARS device manages lateral wound tension to close excisions, lacerations, and incisions in fragile or high tension or at-risk wounds. 
Read More
SUTUREGARD® Medical has formed a non-exclusive distribution partnership with Federated Healthcare Supply to expand market reach of the HEMIGARD® ARS device and the SUTUREGARD® ISR device which are patented wound closure technologies that simplify complex and challenging wound closures.
Read More
SUTUREGARD® has recently announced how to document the use of HEMIGARD® ARS and SUTUREGARD® ISR devices for your complex repairs in EMA with Modernizing Medicine. EMA has clickable boxes to simplify your documentation and coding when using the HEMIGARD® ARS and SUTUREGARD® ISR devices for your closures.
Read More
"When I want to eliminate patient post-op visits for suture removal, I have been using the HEMIGARD device with the retention suture, followed by deeps and top fast gut sutures." Stephanie Howerter, DO, FACMS
Read More
Surgical wound dehiscence is one of the most dreaded & costly of surgical complications. It is disturbing & frightening for the patient, who begins to mistrust or doubt the skill of the surgeon, for the physician who must continue to manage the doctor patient relationship & the challenging wound.
Read More
Suture retention bridges support the primary closure location & reduce the risk of wound dehiscence. SUTUREGARD works to allow for both patients and surgeons easily recover with the SUTUREGARD intraoperative skin relaxation (ISR) and HEMIGARD adhesive suture retention device.
Read More
Our research has demonstrated that the middle suture in an elliptical wound is under approximately six times more force than any subsequent suture. That is why we use the HEMIGARD™ Adhesive Retention Suture device for that middle suture, providing rip-resistant support for healing wounds.
Read More
SUTUREGARD® is pleased to announce CEO, Dan Ladizinsky, MD, will be presenting for the second time at the American Society of Plastic Surgery Annual Meeting, March 12-14, 2020. Ladizinsky is eager to return with the SUTUREGARD® IRS Retention Suture Device and introduce the HEMIGARD™ Device!
Read More
We have previously discussed skin grafts and flaps (link to those posts). The major distinction in a skin flap and skin graft is blood supply. Skin flaps have a connected blood supply. Skin grafts do not have connected blood supply. Recall that the lack of a connected blood supply limits the potential thickness of a skin graft. If the graft is too thick, the blood supply from the wound base may be inadequate and result in partial or total loss of the graft.
Read More
Page 1 of 4 FirstPrevious [1]

Blog Search

 

Relax & Close, More Wounds, More Simply.

Making wound closure easier for surgeons and better for patients.

Order Now